Syngene International shares:The initial update concerns a Good Clinical Practices (GCP) compliance inspection carried out at Syngene’s Semicon Park facility in Bengaluru between June 9 and June 13, 2025. The inspection resulted in no findings, and no Form 483 was issued. It was classified as “No Action Indicated” (NAI), indicating full adherence to regulatory standards.
